Recombinant lipid-tagged antibody fragments as functional cell-surface receptors (Q73401443)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Recombinant lipid-tagged antibody fragments as functional cell-surface receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

de Kruif J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Tijmensen M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Goldsein J

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Logtenberg T

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

223-227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

Lipid-tagged antibodies: bacterial expression and characterization of a lipoprotein-single-chain antibody fusion protein.

3 November 2019

cites work

1 reference

7 January 2021

Functional immunoliposomes harboring a biosynthetically lipid-tagged single-chain antibody.

1 reference

7 January 2021

Biosynthetically lipid-modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes

1 reference

7 January 2021

Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions

1 reference

7 January 2021

Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library

1 reference

7 January 2021

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

1 reference

7 January 2021

Transport and anchoring of beta-lactamase to the external surface of Escherichia coli

1 reference

7 January 2021

Yeast surface display for screening combinatorial polypeptide libraries

1 reference

7 January 2021

Tumor-specific T-bodies: towards clinical application

1 reference

7 January 2021

Signaling pathways in phagocytosis

1 reference

7 January 2021

Human CD14 mediates recognition and phagocytosis of apoptotic cells

1 reference

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

7 January 2021

F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes

1 reference

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

7 January 2021

Genetically modified tumour vaccines--where we are today.

1 reference

7 January 2021

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

1 reference

7 January 2021

An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules

1 reference

7 January 2021

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

7 January 2021

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

7 January 2021

Identifiers

DOI

10.1038/72339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10655115%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference